{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T05:37:17Z","timestamp":1775885837093,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.ejphar.2021.173990","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T09:46:15Z","timestamp":1614505575000},"page":"173990","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat"],"prefix":"10.1016","volume":"898","author":[{"given":"Yuichi","family":"Shinozaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hatsue","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromi","family":"Yoshiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuyoshi","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2021.173990_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1159\/000500487","article-title":"Enarodustat, conversion and maintenance therapy for anemia in hemodialysis patients: a randomized, placebo-controlled phase 2b trial followed by long-term trial","volume":"143","author":"Akizawa","year":"2019","journal-title":"Nephron"},{"key":"10.1016\/j.ejphar.2021.173990_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1159\/000496929","article-title":"A placebo-controlled, randomized trial of enarodustat in patients with chronic kidney disease followed by long-term trial","volume":"49","author":"Akizawa","year":"2019","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173990_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0021-5198(19)39813-0","article-title":"Recombinant human erythropoietin, but not iron supplementation, improves anemia in rats with adjuvant-induced arthritis","volume":"57","author":"Asai","year":"1991","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173990_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ndt\/gfz192","article-title":"Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease","volume":"36","author":"Awan","year":"2021","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ejphar.2021.173990_bib5","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJM199808273390903","article-title":"The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin","volume":"339","author":"Besarab","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.nefro.2017.09.004","article-title":"Anemia of chronic kidney disease: protocol of study, management and referral to Nephrology","volume":"38","author":"Cases","year":"2018","journal-title":"Nefrologia"},{"key":"10.1016\/j.ejphar.2021.173990_bib7","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1901713","article-title":"Roxadustat treatment for anemia in patients undergoing long-term dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib8","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa1813599","article-title":"Roxadustat for anemia in patients with kidney disease not receiving dialysis","volume":"381","author":"Chen","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib9","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/jim-2017-000528","article-title":"Impact of weight loss on inflammation and red blood cell biomarkers after laparoscopic gastric banding surgery","volume":"66","author":"Coimbra","year":"2018","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/NRD.1000101","article-title":"Anemia in patients with chronic kidney disease: current screening and management approaches","volume":"1","author":"Fernando Rivera","year":"2016","journal-title":"Nephrology and Renal Diseases"},{"key":"10.1016\/j.ejphar.2021.173990_bib11","doi-asserted-by":"crossref","first-page":"172532","DOI":"10.1016\/j.ejphar.2019.172532","article-title":"JTZ-951 (enarodustat), a hypoxia-inducibe factor prolyl hydroxylase inhibitor, stabilizes HIF-alpha protein and induces erythropoiesis without effects on the function of vascular endothelial growth factor","volume":"859","author":"Fukui","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2021.173990_bib12","doi-asserted-by":"crossref","first-page":"R330","DOI":"10.1152\/ajpregu.00410.2014","article-title":"Erythropoietin's inhibiting impact on hepcidin expression occurs indirectly","volume":"308","author":"Gammella","year":"2015","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.ejphar.2021.173990_bib13","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejphar.2021.173990_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron balance and the role of hepcidin in chronic kidney disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173990_bib15","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1182\/blood-2011-03-345512","article-title":"Chuvash polycythemia VHLR200W mutation is associated with down-regulation of hepcidin expression","volume":"118","author":"Gordeuk","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2021.173990_bib16","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1093\/cid\/cis010","article-title":"Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children","volume":"54","author":"Gwamaka","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejphar.2021.173990_bib17","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbrc.2018.11.022","article-title":"Retinoic acid modulates iron metabolism imbalance in anemia of inflammation induced by LPS via reversely regulating hepcidin and ferroportin expression","volume":"507","author":"Han","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejphar.2021.173990_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/sdi.12719","article-title":"Anemia in conventional hemodialysis: finding the optimal treatment balance","volume":"31","author":"Hasegawa","year":"2018","journal-title":"Semin. Dial."},{"key":"10.1016\/j.ejphar.2021.173990_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/ijms19020389","article-title":"Hypoxia-inducible factor and its role in the management of anemia in chronic kidney disease","volume":"19","author":"Kaplan","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejphar.2021.173990_bib20","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2215\/CJN.04601007","article-title":"Greater epoetin alfa responsiveness is associated with improved survival in hemodialysis patients","volume":"3","author":"Kilpatrick","year":"2008","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2021.173990_bib21","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s12011-014-0051-3","article-title":"Sex differences in iron status and hepcidin expression in rats","volume":"160","author":"Kong","year":"2014","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.ejphar.2021.173990_bib22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1021\/acsmedchemlett.7b00404","article-title":"Discovery of JTZ-951: a HIF prolyl hydroxylase inhibitor for the treatment of renal anemia","volume":"8","author":"Ogoshi","year":"2017","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2021.173990_bib23","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/bbb\/zbaa013","article-title":"Generation and characterization of monoclonal antibodies against mature hepcidin and its application to neutralization and quantitative alteration assay","volume":"85","author":"Sakamoto","year":"2021","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.ejphar.2021.173990_bib25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1053\/j.ackd.2019.04.004","article-title":"Hypoxia-inducible factor Activators in renal anemia: current clinical experience","volume":"26","author":"Sanghani","year":"2019","journal-title":"Adv. Chron. Kidney Dis."},{"key":"10.1016\/j.ejphar.2021.173990_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2147\/IJNRD.S239151","article-title":"Erythropoietin resistance in patients with chronic kidney disease: current perspectives","volume":"13","author":"Santos","year":"2020","journal-title":"Int. J. Nephrol. Renovascular Dis."},{"key":"10.1016\/j.ejphar.2021.173990_bib27","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0140-6736(06)67962-2","article-title":"Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial","volume":"367","author":"Sazawal","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2021.173990_bib28","doi-asserted-by":"crossref","first-page":"53","DOI":"10.7196\/SAMJ.2016.v106i1.9934","article-title":"Diagnosis of iron deficiency anaemia in hospital patients: Use of the reticulocyte haemoglobin content to differentiate iron deficiency anaemia from anaemia of chronic disease","volume":"106","author":"Schapkaitz","year":"2015","journal-title":"S. Afr. Med. J."},{"key":"10.1016\/j.ejphar.2021.173990_bib29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.cmet.2009.06.009","article-title":"Regulation of intestinal iron absorption: the mucosa takes control?","volume":"10","author":"Simpson","year":"2009","journal-title":"Cell Metabol."},{"key":"10.1016\/j.ejphar.2021.173990_bib30","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1056\/NEJMoa065485","article-title":"Correction of anemia with epoetin alfa in chronic kidney disease","volume":"355","author":"Singh","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2021.173990_bib31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1182\/blood-2018-06-856500","article-title":"Anemia of inflammation","volume":"133","author":"Weiss","year":"2019","journal-title":"Blood"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299921001436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:48:37Z","timestamp":1757976517000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299921001436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":31,"alternative-id":["S0014299921001436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173990","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JTZ-951 (enarodustat), a hypoxia-inducible factor prolyl hydroxylase inhibitor, improves iron utilization and anemia of inflammation: Comparative study against recombinant erythropoietin in rat","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2021.173990","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173990"}}